Crossmark

RETRACTED ARTICLE: Dissecting the role of novel EZH2 inhibitors in primary glioblastoma cell cultures: effects on proliferation, epithelial-mesenchymal transition, migration, and on the pro-inflammatory phenotype

Crossref DOI link: https://doi.org/10.1186/s13148-019-0763-5

Published Online: 2019-12-02

Published Print: 2019-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Stazi, Giulia

Taglieri, Ludovica

Nicolai, Alice

Romanelli, Annalisa

Fioravanti, Rossella

Morrone, Stefania

Sabatino, Manuela

Ragno, Rino

Taurone, Samanta

Nebbioso, Marcella

Carletti, Raffaella

Artico, Marco

Valente, Sergio

Scarpa, Susanna

Mai, Antonello http://orcid.org/0000-0001-9176-2382
Funding

Funding for this research was provided by:

Ricerca Finalizzata 2013 (PE-2013-02355271)

PRIN 2016 (prot. 20152TE5PK)

AIRC 2016 (n. 19162)

National Institutes of Health (n. R01GM114306)
License Information

Text and Data Mining valid from 2019-12-01

Version of Record valid from 2019-12-02
More Information

Article History

Received: 5 June 2019

Accepted: 9 October 2019

First Online: 2 December 2019

Change Date: 7 November 2023

Change Type: Correction

Change Details: This article has been retracted. Please see the Retraction Notice for more detail:

Change Details: https://doi.org/10.1186/s13148-023-01595-6

Ethics approval and consent to participate

: All the authors approved the described studies and consented to participate.

: All the authors approved the publication of the reported data.

: The authors declare that they have no competing interests.

Document is current

Any future updates will be listed below